medigraphic.com
SPANISH

Acta Médica Grupo Angeles

Órgano Oficial del Hospital Angeles Health System
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
    • Send manuscript
    • Names and affiliations of the Editorial Board
  • Policies
  • About us
    • Data sharing policy
    • Stated aims and scope
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2003, Number 4

<< Back

Acta Med 2003; 1 (4)

Tribute to Douglas L. Coleman

Zárate A, Manuel-Apolinar L
Full text How to cite this article

Language: Spanish
References: 0
Page: 104-106
PDF size: 0. Kb.


Key words:

Leptin, obesity, ob/ob mouse.

ABSTRACT

Douglas L. Coleman (October 6, 1931 to April 16, 2014) proposed, using rodent experiments, the theory of the existence of a substance in the circulation that regulates the appetite to prevent obesity. Jeffrey M. Friedman identified the gene expressing the substance and named it leptin, which originated in adipose tissue and reached the hypothalamus, where it was recognized by a specific receptor and thus reduced appetite. According to the kind of mutation, the synthesis of either leptin or its receptor could be deleted, inducing hyperphagia, obesity and diabetes. These findings encouraged the possibility to get a treatment for obesity and were the reason why they were granted the Lasker Award in 2010. It is known that Coleman was nominated for the Nobel Prize, but his death now excludes him.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Acta Med. 2003;1